3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Large-Cell, Anaplastic
3
Immunoblastic Lymphadenopathy
3
Esophageal Neoplasms
3
Burkitt Lymphoma
3
Adenocarcinoma Of Esophagus
3
Sarcoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Sezary Syndrome
1
Rhabdoid Tumor
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Interventions
fludarabine phosphate
22
Mycophenolic Acid
17
Whole-Body Irradiation
15
Peripheral Blood Stem Cell Transplantation
13
Cyclophosphamide
12
Cyclosporine
11
Tacrolimus
10
Cyclosporins
9
Antilymphocyte Serum
9
Busulfan
8
fludarabine
7
Rituximab
7
Sirolimus
5
Methotrexate
5
Melphalan
4
Filgrastim
3
Cytarabine
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
pegfilgrastim
2
ibrutinib
2
Thiotepa
2
Oxaliplatin
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Darbepoetin alfa
2
Clofarabine
2
selinexor
1
sargramostim
1
ofatumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic
×
Microarray Analysis
×
Clear all
No trials found.